DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
- Status
- COMPLETED
- Phase
- PHASE2
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- Status
- RECRUITING
- Phase
- N/A
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
- Status
- RECRUITING
- Phase
- NA
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS
- Status
- COMPLETED
- Phase
- NA
Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention
- Status
- COMPLETED
- Phase
- NA
Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Rituximab + Immunotherapy in Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1